DR. BARRY TEDDER, M.D.

Plain English
This study looked at how very-low-carbohydrate diets (VLCD) affect cholesterol levels, especially in people with a low body mass index (BMI) and a specific genetic variation called ABCG5. They reported a case of a 51-year-old woman whose cholesterol skyrocketed from 142 mg/dL to over 555 mg/dL on a VLCD, and found that in a large group of 224,126 people, those with a BMI below 20 kg/m² had much higher cholesterol ratios compared to those with obesity. This is important because it shows that low BMI can lead to dangerous increases in cholesterol when on these diets, particularly in those with the ABCG5 genetic variant, which may help doctors make better dietary recommendations for at-risk patients. Who this helps: This helps patients, especially those with low BMI or genetic variations affecting lipid metabolism.

Plain English
This study looks at how patients with relapsed multiple myeloma are responding to new treatments that target a protein called BCMA, such as CAR T-cell therapies and bispecific antibodies. Despite initial successes, many patients experience setbacks due to resistance mechanisms that the cancer cells develop, which makes treatments less effective over time. By understanding how these resistance mechanisms work and exploring new treatment strategies, the research aims to improve the effectiveness and longevity of these therapies for patients. Who this helps: Patients with relapsed multiple myeloma.

Plain English
The DETOUR2 trial studied a new procedure called percutaneous transmural arterial bypass (PTAB) to treat severe blockages in the arteries of the legs. The study involved 202 patients, with 200 receiving treatment, and found that after one year, 72% of them still had open arteries, while 97% showed improvement in their condition. This matters because the treatment was safe, with 93% of patients avoiding major complications within 30 days, indicating it could be a reliable option for patients suffering from extensive artery blockages. Who this helps: Patients with severe leg artery disease.

Plain English
This study looked at trends in deaths from gastrointestinal cancers in the U.S. from 1999 to 2020, analyzing data based on sex, age, and race. Overall, deaths decreased from 46.7 per 100,000 people in 1999 to 38.4 per 100,000 in 2020, but certain types of cancers, like pancreatic and liver cancer, saw increases in mortality. It's important to understand these changes as they reveal disparities among different racial groups, indicating where more research and healthcare efforts are needed. Who this helps: This helps patients and healthcare providers by highlighting trends in cancer mortality and identifying areas that require more attention and resources.

Plain English
This study looked at patients with extrahepatic cholangiocarcinoma (eCCA) to find out how long they lived after different treatments from 2000 to 2018. The researchers found that survival rates improved, especially for those who had surgery along with chemotherapy or radiation. For example, surgery with chemotherapy or radiation reduced the risk of death by about 31% to 32% compared to surgery alone, and removing four or more lymph nodes lowered the risk of death by 58%. This information is important because it highlights the benefits of combined treatments, which can greatly improve survival for patients with eCCA. Who this helps: This helps patients with extrahepatic cholangiocarcinoma and their doctors in making informed treatment decisions.

Plain English
This study looked at how often people are diagnosed with intrahepatic cholangiocarcinoma (a type of liver cancer) and how long they survive after being diagnosed. It found that between 2000 and 2017, the rate of new cases increased, particularly in White males, while survival rates at 1, 3, and 5 years were 36.3%, 12.8%, and 8.1%, respectively. People who had their lymph nodes removed during surgery had a 64.1% lower risk of dying compared to those who didn't have surgery, highlighting the importance of surgical treatment for better outcomes. Who this helps: This helps patients with intrahepatic cholangiocarcinoma and their doctors by informing treatment decisions.

Plain English
This study looked at a new medical device called the Pantheris catheter, which uses advanced imaging technology to help treat blockages in leg arteries caused by a condition known as femoropopliteal disease. Researchers treated 198 blockages and found that 97% of them had a significant reduction in blockage after using the device, going from an average of 78.7% blockage to just 22.4%. The study also showed that the procedure was safe, with only 16.6% of patients experiencing major complications within six months, highlighting that this method can effectively open blocked arteries while minimizing damage to surrounding tissues. Who this helps: Patients with blocked leg arteries.